DocGo (NASDAQ:DCGO) Receives “Buy” Rating from Needham & Company LLC

Needham & Company LLC reaffirmed their buy rating on shares of DocGo (NASDAQ:DCGO) in a research note released on Monday morning, Benzinga reports. They currently have a $14.00 price objective on the stock.

Several other research analysts also recently weighed in on DCGO. Cantor Fitzgerald reiterated an overweight rating and issued a $13.00 price target on shares of DocGo in a report on Thursday, September 14th. BTIG Research began coverage on DocGo in a report on Friday, August 18th. They issued a buy rating and a $15.00 price target for the company. Stifel Nicolaus reiterated a buy rating and issued a $12.00 price target on shares of DocGo in a report on Monday, July 31st. Finally, Northland Securities boosted their price target on DocGo from $15.00 to $16.00 in a report on Tuesday, August 8th.

DocGo Price Performance

Shares of NASDAQ:DCGO opened at $5.29 on Monday. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.56 and a quick ratio of 2.56. DocGo has a 12 month low of $4.88 and a 12 month high of $11.41. The firm has a market capitalization of $549.05 million, a price-to-earnings ratio of 75.57 and a beta of 0.85. The business’s 50 day simple moving average is $8.60 and its 200-day simple moving average is $8.69.

DocGo (NASDAQ:DCGO) last issued its quarterly earnings data on Monday, August 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.05). DocGo had a return on equity of 3.20% and a net margin of 1.27%. The company had revenue of $125.49 million for the quarter, compared to analyst estimates of $119.64 million. As a group, equities analysts forecast that DocGo will post 0.09 earnings per share for the current fiscal year.

Insider Buying and Selling at DocGo

In other DocGo news, insider Adriaan Stephanus Oberholzer sold 50,000 shares of the firm’s stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $10.15, for a total value of $507,500.00. Following the sale, the insider now owns 1,193,413 shares in the company, valued at $12,113,141.95. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, insider Adriaan Stephanus Oberholzer sold 50,000 shares of the stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $10.15, for a total value of $507,500.00. Following the completion of the transaction, the insider now directly owns 1,193,413 shares in the company, valued at $12,113,141.95. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, General Counsel Ely D. Tendler sold 10,000 shares of the stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $8.75, for a total transaction of $87,500.00. Following the completion of the transaction, the general counsel now owns 23,088 shares of the company’s stock, valued at $202,020. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 62,000 shares of company stock worth $613,000. 13.78% of the stock is owned by company insiders.

Institutional Trading of DocGo

A number of large investors have recently added to or reduced their stakes in the business. Nuveen Asset Management LLC boosted its holdings in DocGo by 1.1% during the second quarter. Nuveen Asset Management LLC now owns 328,866 shares of the company’s stock worth $3,081,000 after buying an additional 3,423 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in DocGo by 67.2% during the second quarter. Wells Fargo & Company MN now owns 40,926 shares of the company’s stock worth $383,000 after buying an additional 16,456 shares in the last quarter. Integrated Wealth Concepts LLC bought a new stake in DocGo during the second quarter worth approximately $175,000. Dana Investment Advisors Inc. boosted its holdings in DocGo by 7.1% during the second quarter. Dana Investment Advisors Inc. now owns 210,273 shares of the company’s stock worth $1,970,000 after buying an additional 13,951 shares in the last quarter. Finally, Captrust Financial Advisors bought a new stake in DocGo during the second quarter worth approximately $868,000. 52.14% of the stock is currently owned by institutional investors.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.